AMLX icon

Amylyx Pharmaceuticals
AMLX

Overview Fund Trends Analyst Outlook Journalist POV

72 hedge funds and large institutions have $300M invested in Amylyx Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership: →

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.76M
Puts
$533K
Net Calls
Net Calls Change

Top Buyers

1
+$92.1M
2
+$35.4M
3
+$28.3M
4
PA
Perceptive Advisors
New York
+$18.9M
5
RSCM
Rock Springs Capital Management
Maryland
+$12.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$92.1M
2
$35.4M
3
$28.3M
4
$18.9M
5
$12.8M
6
$12.8M
7
$11.9M
8
$9.88M
9
$7.93M
10
$7.68M
11
$7.51M
12
$7.35M
13
$6.45M
14
$5.17M
15
$5.1M
16
$5.01M
17
$2.44M
18
$2.06M
19
$1.88M
20
$1.76M
21
$1.28M
22
$1.27M
23
$1.16M
24
$1.13M
25
$1.06M
1
2 3